2011-05-27
Amendment of the Patent Act regarding new medical uses
1 July 2011, an amendment to § 2 Patent Act enters into force, which means that the possibility of granting patents for new medical uses of per se known substances will be expressly stated. The possibility of patenting so-called subsequent medical indications already exists in Sweden, and the constitutional amendment is the sole purpose of clarification, as part of harmonization efforts in relation to the EPC.
